{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:15:58Z","timestamp":1791951358835,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01MH085667"],"award-info":[{"award-number":["1R01MH085667"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jpsychires.2014.04.017","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T21:30:40Z","timestamp":1398979840000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Inflammatory mediators of cognitive impairment in bipolar disorder"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-9354","authenticated-orcid":false,"given":"Isabelle E.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela C.","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Wollenhaupt-Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2014.04.017_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pnpbp.2013.07.008","article-title":"BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses","volume":"46","author":"Aas","year":"2013","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0447.2009.01532.x","article-title":"Sustained attention as a potential endophenotype for bipolar disorder","volume":"122","author":"Ancin","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2011.07.031","article-title":"Circulating levels of GDNF in bipolar disorder","volume":"502","author":"Barbosa","year":"2011","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"2012","journal-title":"J\u00a0Affect Disord"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.psychres.2005.08.010","article-title":"Patterns of memory impairment in bipolar disorder and unipolar major depression","volume":"142","author":"Bearden","year":"2006","journal-title":"Psychiatry Res"},{"issue":"4 Suppl","key":"10.1016\/j.jpsychires.2014.04.017_bib6","first-page":"S36","article-title":"From neuroprogression to neuroprotection: implications for clinical care","volume":"193","author":"Berk","year":"2010","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/glia.22372","article-title":"Microglia as modulators of cognition and neuropsychiatric disorders","volume":"61","author":"Blank","year":"2013","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.jpsychires.2014.04.017_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0891988712464821","article-title":"The frontal assessment battery in the differential diagnosis of dementia","volume":"25","author":"Boban","year":"2012","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acps.12133","article-title":"Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis","volume":"128","author":"Bourne","year":"2013","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.jpsychires.2014.04.017_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000054897","article-title":"Differential effects of age on brain gray matter in bipolar patients and healthy individuals","volume":"43","author":"Brambilla","year":"2001","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib12","first-page":"1","article-title":"Brain derived neurotropic factor in first-episode psychosis","volume":"91","author":"Buckley","year":"2007","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0889-1591(02)00078-8","article-title":"Cytokines and depression: the need for a new paradigm","volume":"17","author":"Capuron","year":"2003","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1179\/1476830512Y.0000000023","article-title":"The ability of walnut extract and fatty acids to protect against the deleterious effects of oxidative stress and inflammation in hippocampal cells","volume":"16","author":"Carey","year":"2013","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.jpsychires.2014.04.017_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2012.05.043","article-title":"Impaired cognition in bipolar I disorder: the roles of the serotonin transporter and brain-derived neurotrophic factor","volume":"143","author":"Chou","year":"2012","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jpsychires.2014.04.017_bib16","series-title":"Cochrane reviewers' handbook. Version 4.2.1","author":"Cochrane, Collaboration","year":"2003"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2005.030718","article-title":"The genetics of schizophrenia and bipolar disorder: dissecting psychosis","volume":"42","author":"Craddock","year":"2005","journal-title":"J\u00a0Med Genet"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","article-title":"Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes","volume":"398","author":"Cunha","year":"2006","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.jpsychires.2014.04.017_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00406-007-0728-0","article-title":"What causes the hippocampal volume decrease in depression?","volume":"257","author":"Cz\u00e9h","year":"2007","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tem.2006.02.006","article-title":"The use of mifepristone in the treatment of neuropsychiatric disorders","volume":"17","author":"DeBattista","year":"2006","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jpsychires.2014.04.017_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1399-5618.2009.00733.x","article-title":"Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder","volume":"11","author":"Dias","year":"2009","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","article-title":"Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder","volume":"150","author":"Dickerson","year":"2013","journal-title":"J\u00a0Affect Disord"},{"issue":"5","key":"10.1016\/j.jpsychires.2014.04.017_bib23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.pnpbp.2011.04.009","article-title":"Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers","volume":"35","author":"Diwadkar","year":"2011","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","article-title":"Levels of TNF-\u03b1, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder","volume":"28","author":"Doganavsargil-Baysal","year":"2013","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"8","key":"10.1016\/j.jpsychires.2014.04.017_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis","volume":"45","author":"Fernandes","year":"2011","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jpsychires.2014.04.017_bib26","series-title":"Structured Clinical Interview for DSM-IV\u00ae Axis I Disorders (SCID-I), Clinician Version, Administration Booklet","author":"First","year":"2012"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.brainres.2006.04.076","article-title":"Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure","volume":"1097","author":"Frey","year":"2006","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.jpsychires.2014.04.017_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11064-006-9070-6","article-title":"Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"Neurochem Res"},{"issue":"10","key":"10.1016\/j.jpsychires.2014.04.017_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.euroneuro.2008.04.015","article-title":"Illness duration and total brain gray matter in bipolar disorder: evidence for neurodegeneration?","volume":"18","author":"Frey","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.jpsychires.2014.04.017_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11920-012-0319-2","article-title":"Staging and neuroprogression in bipolar disorder","volume":"14","author":"Fries","year":"2012","journal-title":"Curr Psychiatry Rep"},{"issue":"48","key":"10.1016\/j.jpsychires.2014.04.017_bib31","first-page":"295","article-title":"Is there an association between peripheral immune markers and structural\/functional neuroimaging findings?","volume":"3","author":"Frodl","year":"2013","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.rbp.2012.09.001","article-title":"Staging and neuroprogression in bipolar disorder: a systematic review of the literature","volume":"35","author":"Gama","year":"2013","journal-title":"Rev Bras Psiquiatr"},{"issue":"5","key":"10.1016\/j.jpsychires.2014.04.017_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1399-5618.2012.01033.x","article-title":"Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis","volume":"14","author":"Gigante","year":"2012","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0033291708003723","article-title":"Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study","volume":"39","author":"Gimeno","year":"2009","journal-title":"Psychol Med"},{"issue":"8","key":"10.1016\/j.jpsychires.2014.04.017_bib35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biopsych.2007.02.001","article-title":"The neurocognitive signature of psychotic bipolar disorder","volume":"62","author":"Glahn","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNN.0b013e31828b7d26","article-title":"Cognitive performance on the mini-mental state examination and the Montreal cognitive assessment across the healthy adult lifespan","volume":"26","author":"Gluhm","year":"2013","journal-title":"Cogn Behav Neurol"},{"issue":"5","key":"10.1016\/j.jpsychires.2014.04.017_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/cap.2011.0009","article-title":"Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders","volume":"21","author":"Goldstein","year":"2011","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1440-1819.2008.01918.x","article-title":"Increased soluble tumor necrosis factor-\u03b1 receptors in patients with major depressive disorder","volume":"63","author":"Grassi-Oliveira","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.jpsychires.2014.04.017_bib39","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1542\/peds.2007-0391","article-title":"Mitochondrial disease: a practical approach for primary care physicians","volume":"120","author":"Haas","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpsychires.2014.04.017_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpsychires.2012.11.015","article-title":"A\u00a0systematic review of studies of depression prevalence in university students","volume":"47","author":"Ibrahim","year":"2012","journal-title":"J\u00a0Psychiatr Res"},{"issue":"11","key":"10.1016\/j.jpsychires.2014.04.017_bib42","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.yexcr.2012.03.006","article-title":"Neurotrophins and cell death","volume":"318","author":"Ichim","year":"2012","journal-title":"Exp Cell Res"},{"issue":"9","key":"10.1016\/j.jpsychires.2014.04.017_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jnutbio.2008.07.003","article-title":"The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice","volume":"20","author":"Jiang","year":"2009","journal-title":"J\u00a0Nutr Biochem"},{"issue":"4","key":"10.1016\/j.jpsychires.2014.04.017_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","article-title":"Allostatic load in bipolar disorder: implications for pathophysiology and treatment","volume":"32","author":"Kapczinski","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"10.1016\/j.jpsychires.2014.04.017_bib45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1586\/ern.09.31","article-title":"Clinical implications of a staging model for bipolar disorders","volume":"9","author":"Kapczinski","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J\u00a0Psychiatr Res"},{"issue":"10","key":"10.1016\/j.jpsychires.2014.04.017_bib47","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0022-2275(20)37132-7","article-title":"Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study","volume":"38","author":"Katan","year":"1997","journal-title":"J\u00a0Lipid Res"},{"issue":"04","key":"10.1016\/j.jpsychires.2014.04.017_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant'Anna","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2014.04.017_bib49","series-title":"Neuropsychological assessment of neuropsychiatric disorders","article-title":"Cognitive impairment and major depression: beyond the pseudodementia syndrome","author":"King","year":"1996"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib50","first-page":"268","article-title":"Serum levels of IL-6, IL-10 and TNF-\u03b1 in patients with bipolar disorder and schizophrenia: differences in pro-and anti-inflammatory balance","volume":"33","author":"Kunz","year":"2011","journal-title":"Rev Bras Psiquiatr"},{"issue":"4","key":"10.1016\/j.jpsychires.2014.04.017_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/00048670701213211","article-title":"Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia","volume":"41","author":"Mackin","year":"2007","journal-title":"Aust N Z J Psychiatry"},{"issue":"1-2","key":"10.1016\/j.jpsychires.2014.04.017_bib52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1399-5618.2007.00324.x","article-title":"Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia","volume":"9","author":"Malhi","year":"2007","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","article-title":"Apoptosis in neurodegenerative disorders","volume":"1","author":"Mattson","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.1998.6863","article-title":"Evidence for synaptic apoptosis","volume":"153","author":"Mattson","year":"1998","journal-title":"Exp Neurol"},{"issue":"7","key":"10.1016\/j.jpsychires.2014.04.017_bib55","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.04.017_bib56","series-title":"Inflammatory disorders of the nervous system: pathogenesis, immunology, and clinical management","author":"Minagar","year":"2005"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jpsychires.2014.04.017_bib57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0034-7450(14)60201-8","article-title":"Mitochondrial dysfunction in bipolar disorder: lessons from brain imaging and molecular markers","volume":"40","author":"Minuzzi","year":"2011","journal-title":"Rev Colomb Psiquiatr"},{"issue":"6","key":"10.1016\/j.jpsychires.2014.04.017_bib58","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cmet.2013.07.006","article-title":"Mitochondrial dysfunction indirectly elevates ROS production by the endoplasmic reticulum","volume":"18","author":"Murphy","year":"2013","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11011-008-9114-5","article-title":"Neuropsychiatric disorders related to interferon and interleukins treatment","volume":"24","author":"Myint","year":"2009","journal-title":"Metab Brain Dis"},{"issue":"5","key":"10.1016\/j.jpsychires.2014.04.017_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.euroneuro.2006.10.002","article-title":"Impulsivity and bipolar disorder","volume":"17","author":"Najt","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2006.08.009","article-title":"Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression","volume":"21","author":"Pace","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.1016\/j.jpsychires.2014.04.017_bib63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1440-1819.2012.02400.x","article-title":"Neuropsychological performance in euthymic Indian patients with bipolar disorder type I: correlation between quality of life and global functioning","volume":"66","author":"Pattanayak","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.jpsychires.2014.04.017_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/npy.12.35","article-title":"Anatomical faces of neuroprogression in bipolar disorder","volume":"2","author":"Pfaffenseller","year":"2012","journal-title":"Neuropsychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0165-0327(02)00091-5","article-title":"Neuropsychology of bipolar disorder: a review","volume":"72","author":"Quraishi","year":"2002","journal-title":"J\u00a0Affect Disord"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2014.04.017_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2006.02.016","article-title":"A\u00a0meta-analysis of cognitive deficits in euthymic patients with bipolar disorder","volume":"93","author":"Robinson","year":"2006","journal-title":"J\u00a0Affect Disord"},{"issue":"05","key":"10.1016\/j.jpsychires.2014.04.017_bib67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S1461145710000404","article-title":"Excellent lithium responders have normal cognitive functions and plasma BDNF levels","volume":"13","author":"Rybakowski","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.jpsychires.2014.04.017_bib68","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1399-5618.2003.00071.x","article-title":"Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients","volume":"5","author":"Rybakowski","year":"2003","journal-title":"Bipolar Disord"},{"issue":"1","key":"10.1016\/j.jpsychires.2014.04.017_bib69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1819.2006.01462.x","article-title":"Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene","volume":"60","author":"Rybakowski","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"10.1016\/j.jpsychires.2014.04.017_bib70","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability","volume":"12","author":"Sheehan","year":"1997","journal-title":"Eur Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2014.04.017_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jpsychires.2014.04.017_bib72","series-title":"The bipolar brain: integrating neuroimaging and genetics","author":"Strakowski","year":"2012"},{"issue":"4","key":"10.1016\/j.jpsychires.2014.04.017_bib73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1399-5618.2012.01022.x","article-title":"The functional neuroanatomy of bipolar disorder: a consensus model","volume":"14","author":"Strakowski","year":"2012","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.jpsychires.2014.04.017_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1590\/S1516-44462009000200010","article-title":"Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder","volume":"31","author":"Tramontina","year":"2009","journal-title":"Rev Bras Psiquiatr"},{"issue":"6","key":"10.1016\/j.jpsychires.2014.04.017_bib75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40263-013-0067-9","article-title":"Publication bias, with a focus on psychiatry: causes and solutions","volume":"27","author":"Turner","year":"2013","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.jpsychires.2014.04.017_bib76","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.biopsych.2012.05.029","article-title":"A\u00a0randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression","volume":"72","author":"Watson","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"29","key":"10.1016\/j.jpsychires.2014.04.017_bib77","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","article-title":"Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder","volume":"8","author":"Young","year":"2004","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239561400123X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239561400123X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:09:34Z","timestamp":1758366574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239561400123X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":77,"alternative-id":["S002239561400123X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.04.017","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory mediators of cognitive impairment in bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}